REVIR Trademark

Trademark Overview


On Thursday, December 30, 2021, a trademark application was filed for REVIR with the United States Patent and Trademark Office. The USPTO has given the REVIR trademark a serial number of 97196820. The federal status of this trademark filing is REGISTERED as of Tuesday, January 24, 2023. This trademark is owned by Revir Therapeutics, Inc.. The REVIR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consulta...
revir

General Information


Serial Number97196820
Word MarkREVIR
Filing DateThursday, December 30, 2021
Status700 - REGISTERED
Status DateTuesday, January 24, 2023
Registration Number6963622
Registration DateTuesday, January 24, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements


Description of MarkThe mark consists of stylized wording "REVIR".
Goods and ServicesScientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease, metabolic diseases; Providing medical and scientific research information, consultancy, and advisory services in the fields of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease; Compiling data for medical and scientific research, clinical trials, and drug admission

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 5, 2022
Primary Code042
First Use Anywhere DateMonday, May 10, 2021
First Use In Commerce DateMonday, May 10, 2021

Trademark Owner History


Party NameRevir Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Party NameRevir Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Party NameRevir Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Trademark Events


Event DateEvent Description
Tuesday, January 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 24, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, October 5, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 5, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, October 5, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 4, 2022ASSIGNED TO EXAMINER
Thursday, September 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 1, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 3, 2022NEW APPLICATION ENTERED